Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization

PURPOSE: Amphotericin B (AmB) is an effective anti-fungal and anti-leishmanial agent. However, AmB has low oral bioavailability (0.3%) and adverse effects (e.g., nephrotoxicity). The objectives of this study were to improve the oral bioavailability by entrapping AmB in pegylated (PEG) poly lactide c...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Quadeib, Bushra T., Radwan, Mahasen A., Siller, Lidija, Horrocks, Benjamin, Wright, Matthew C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475820/
https://www.ncbi.nlm.nih.gov/pubmed/26106277
http://dx.doi.org/10.1016/j.jsps.2014.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475820/
https://www.ncbi.nlm.nih.gov/pubmed/26106277
http://dx.doi.org/10.1016/j.jsps.2014.11.004

Ejemplares similares